IBO 8-K: Acquisition

Filed with the SEC on · accession 0001493152-26-052822

IBO filed a 8-K (current report) with the SEC on Nov 17, 2026. Impact Biomedical stockholders approved a merger and share exchange agreement with Zoar Limited (f.k.a. The stock moved +19.7% by the first close after the filing.

Summary of the filing

Impact Biomedical stockholders approved a merger and share exchange agreement with Zoar Limited (f.k.a. Dr Ashleys Limited) and Zoar Labs Limited, along with a new board of directors and other governance items.

Key details

Registrant/acquirerImpact Biomedical Inc.
Pubco in mergerZoar Limited (f.k.a. Dr Ashleys Limited)
Target company in mergerZoar Labs Limited (f.k.a. Dr Ashleys Bio Labs Limited)
Merger subsidiaryDr Ashleys Nevada Sub, Inc.
Independent registered public accounting firm (ratified)Grassi & Co. Certified Public Accountants, P.C.
Chief executive officer / director nomineeFrank D. Heuszel
Director nomineeElise Brownell
Director nomineeMelissa Sims
Director nomineeCastel Hibbert
Director nomineeDavid Keene
Director nomineeChristian Zimmerman
Director nomineeJason Grady
Director nomineeChan Heng Fai Ambrose
Sole stockholder of zoarKanans Visvanats (a.k.a. Kannan Vishwanatth)

How IBO stock reacted

Close before

$4.91

Nov 16, 2026

First close after

+19.66%

$5.88

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for IBO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for IBO?

Click here

Frequently asked questions

What did IBO file with the SEC on Nov 17, 2026?

IBO filed a 8-K (Acquisition). Impact Biomedical stockholders approved a merger and share exchange agreement with Zoar Limited (f.k.a. Dr Ashleys Limited) and Zoar Labs Limited, along with a new board of directors and other governance items.

What does a acquisition mean for IBO stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did IBO stock react to this filing?

IBO closed at $4.91 before the filing and $5.88 on Nov 17, 2026 (+19.66%).

Other IBO SEC filings

Get alerts when IBO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days